Steven Tregay, Ph.D. Founder, President and CEO
Since our start in 2008,
FORMA Therapeutics has made significant progress in targeting essential targets and pathways relevant to cancer and have identified multiple series of potential drug candidates that continue development within FORMA and our collaborators. As you explore our website you will learn about our unique and aggressive approach to drug discovery.
» more